Effect of a dysmenorrhea Chinese medicinal prescription on uterus contractility in vitro

Phytotherapy Research

Volumn 17, Issue 7, 2003, Pages 778-783

  Hsu, Chun Sen ^a   Yang, J Kay ^b   Yang, Ling Ling ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

Ergonovine; KCl, Wen Jing Tang; Oxytocin; PGF2 , ACh; Propranolol

Indexed keywords

ACETYLCHOLINE; CHINESE DRUG; ERGOMETRINE; OXYTOCIN; POTASSIUM CHLORIDE; PROPRANOLOL; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG; WEN JING TANG;

ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DEPOLARIZATION; DRUG ISOLATION; DRUG MECHANISM; DRUG SOLUTION; DYSMENORRHEA; FEMALE; IN VITRO STUDY; MYOMETRIUM; NONHUMAN; PRESCRIPTION; RAT; UTERUS CONTRACTILITY;

ACETYLCHOLINE; ANIMALS; DRUGS, CHINESE HERBAL; DYSMENORRHEA; FEMALE; MEDICINE, CHINESE TRADITIONAL; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OXYTOCICS; PHYTOTHERAPY; PLANT EXTRACTS; POTASSIUM CHLORIDE; PROSTAGLANDINS F; RATS; RATS, WISTAR; UTERUS;

EID: 0042011099     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1235     Document Type: Article

References (29)

1. Andrea JR. 1996. Pelvic pain and dysmenorrhea. In Novak's Gynecology 12th edn, Berek JS, Adashi E, Hillard PA (eds). Williams & Wilkins: Baltimore; 399-426.
2. Ballejo G, Calixto JB, Medeiros YS. 1986. 'In vitro' effects of calcium entry blockers, chlorpromazine and fenoterol upon human pregant myometrium contractility. Br J Pharmacol 89: 515-516.
3. Bolton TB. 1979. Mechanism of action of transmitters and other substances on smooth muscle. Phys Rev 59: 606-609.
4. Brody W, Schwartz L. 1993a. Human Pharmacology: Estrogens, Progestins, and Oral Contraceptives: Mosby Inc., St Louis MO, US; 493-513.
5. Brody W, Schwartz L. 1993b. Human Pharmacology: Drugs Affecting Uterine Motility: Mosby Inc., St Louis MO; 555-560.
6. Calixto JB, Yunes RA, Rae GA. 1991. Effect of crude extracts from Leonotis nepetaefolia (Labiatae) on rat and guinea-pig smooth muscle and rat cardiac muscle. J Pharm Pharmacol 43(8): 529-534.
7. Carsten M, Jordan DM. 1987. A new look at uterine muscle contraction. Am J Obstet Gynecol 157: 1303-1304.
8. Dawood MY. 1990. Dysmenorrhea. Clin Obstet Gynecol 33(1): 168-178.
9. Evans JM, McMahon AD, Murray FE, et al. 1997. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 40(5): 619-622.
10. Garcia-Rodriguez LA, Jick H. 1994a. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 343(8900): 769-772.
11. Garcia-Rodriguez LA, Williams R, Derby LE, et al. 1994b. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med 154(3): 311-316.
12. Ghodgaonkar RB, Dubin NH, Blake DA. 1979. 13,14-dihydro-15 Keto-prostaglandin F2α concentration in human plasma and amniotic fluid. Am J Obstet Gynecol 134: 265-268.
13. Gordan PL, Jenkins SL, Wentworth RA, Nathanielsz PW. 1997. Effects of in vivo estradiol administration to bilaterally ovariectomized rats on in vitro myometrial responsiveness to prostaglandin F2α and oxytocin. Biol Reprod 57(3): 597-601.
14. Harlow SD, Park M. 1996. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol 103 (11): 1134-1142.
15. Horowitz A, Menice CB, Laporte KG. 1996. Mechanisms of smooth muscle contraction. Phys Rev 76: 967-1003.
16. Hurwitz L. 1986. Pharmacology of calcium channels and smooth muscle. Pharmacol Toxicol 26: 225-258.
17. Macht DI, Davis ME. 1934. Experimental studies, old and new, on menstrual toxin. J. Comp Psychol 18: 113-134.
18. Maxson WS, Rosenwaks Z. 1993. Dysmenorrhea and premenstrual syndrome. In Textbook of Gynecology; Copeland LJ, Jarrell JF, McGregor JA (eds). W.B. Saunders company: Philadelphia, PA; 398-413.
19. Montero P, Bernis C, Fernandez V, Castro S. 1996. Influence of body mass index and slimming habits on menstrual pain and cycle irregularity. J Bioscience 28(3): 315-323.
20. Perez Gutthann S, Garcia-Rodriguez LA, Raiford DS, et al. 1996. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med 156(21): 2433-2439.
21. Perez-Vallina JR, Cantabrana B, Hidalgo A. 1995. Calcium- and G-protein-related spasmolytic effects of nonsteroidal anti-inflammatory drugs on rat uterus contractions In vitro. Pharmacology 50(5): 324-332.
22. Pilar D'Ocon, Rafael B, Candenas L, et al. 1991. Inhibition of calcium entry induced by cularines and isocrasfoline in uterine smooth muscle. Eur J Pharmacol 196: 183-187.
23. Radford MG Jr, Holley KE, Grande JP, et al. 1996. Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. J Am Med Assoc 276(6): 466-469.
24. Rodger IW. 1992. Airway smooth muscle. Br Med Bull 48: 97-107.
25. Rosenwaks Z, Jomes GS, Henzl MR. 1981. Naproxen sodium, aspirin, and placebo in primary dysmnorrhea: Reduction of pain and blood levels for prostaglandin F2α metabolite. Am J Obstet Gynecol 140: 592-594.
26. 2 on the contractility of the non-pregnant human uterus in vivo. Acta Obstet Gyrecol Scand Supplement 5: 10-25.
27. Tolman KG. 1998. Hepatotoxicity of non-narcotic analgesics. Am J Med 105(1B): 13S-19S.
28. Triggle DJ, Langs DA, Janis RA. 1989. Ca-channel ligands: structure-function relationships of the 1,4-dihydropyridines. Med Res Rev 9(2): 123-180.
29. Zafra-Polo MC, Tormos MJ, Cortes D, Anselmi E. 1993. Comparative study of the rat uterine smooth muscle relaxant activity of three bisbenzyl-tetrahydroisoquinolines with tetrandrine. J Pharm Pharmacol 45(6): 563-566.